Page last updated: 2024-09-02

fingolimod hydrochloride and Stillbirth

fingolimod hydrochloride has been researched along with Stillbirth in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguilera, C; Tintoré, M; Tur, C	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Stillbirth

Article	Year
[Disease modifying drugs in multiple sclerosis and pregnancy]. Medicina clinica, 2012, Sep-22, Volume: 139, Issue:7 Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antibodies, Monoclonal, Humanized; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressive Agents; Infant, Newborn; Interferon-beta; Multiple Sclerosis; Natalizumab; Peptides; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Propylene Glycols; Sphingosine; Stillbirth	2012

Article

Year

[Disease modifying drugs in multiple sclerosis and pregnancy].

Medicina clinica, 2012, Sep-22, Volume: 139, Issue:7

Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antibodies, Monoclonal, Humanized; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressive Agents; Infant, Newborn; Interferon-beta; Multiple Sclerosis; Natalizumab; Peptides; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Propylene Glycols; Sphingosine; Stillbirth

2012